30.6.2020
•
News
Corporate law
KŠB advises its long-term client Solitea on merger of dozens of companies
Solitea Holding, which is engaged in developing business, accounting and HR solutions and has more than 260,000 customers in 15 countries, will merge thirty companies from the Czech Republic and Slovakia into two national companies with effect from 1 July. The merger is primarily designed to streamline and simplify communications and administration.
KŠB’s team (partner Drahomír Tomašuk and lawyers Josef Kříž, Michal Hanuš, Ján Béreš and Jana Guričová) advised Solitea Holding on the merger, which had been in preparation for more than a year, and was in charge of drafting and preparing all related legal documentation, including the merger project, corporate approvals, labour-law matters, etc.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
